M. S. Javed, Ghulam Subhani, M. Akmal, M. Munir, S. Javed
{"title":"Tramadol or Nalbuphine; Which One is Superior for Analgesia in Post-Operative Period after Percutaneous Nephrolithotomy","authors":"M. S. Javed, Ghulam Subhani, M. Akmal, M. Munir, S. Javed","doi":"10.29054/APMC/2021.1062","DOIUrl":null,"url":null,"abstract":"Background: Kidney stones has got high prevalence worldwide especially in our part of world and per-cutaneous nephrolithotomy (PCNL) is gold standard operative modality for renal stone management. Pain control after PCNL is the most important task for treating surgeon as effective pain control causes smooth patient recovery in post-operative period. For analgesia, many drugs can be used, out of which tramadol and nalbuphine always been in comparison for effective analgesic activity. Objective: To compare efficacy of tramadol and nalbuphine as potent analgesic in patients after PCNL. Study Design: A prospective randomized study. Settings: Department of Urology and Kidney Transplantation, Allied Hospital/Faisalabad Medical University, Faisalabad and Department of Urology, DHQ Hospital/Faisalabad Medical University, Faisalabad Pakistan. Duration: From September 2016 to September 2020 (4 Years). Methodology: 286 patients undergoing PCNL for either gender and sides enrolled in study according to inclusion and exclusion criteria. Patients divided into Group A (Administered with tramadol) and Group B (administered with nalbuphine) and patients evaluated for pain up to 48 hours after surgery using 11-point numerical pain rating scale rating from0-10 where 0 is no pain, 1-3 mild pain, 4-6 moderate pain, 7-9 severe pain and 10 as worst pain and use of rescue analgesia observed in either groups. Data obtained and statistical evaluation done. Results: 286 patients enrolled from age 15-75 years with mean age of 40.2 years. Among 286 patients, 161 were male and 125 were female patients. Both groups A and B having 143 patients each. Analysis showed that tramadol has superiority over nalbuphine and need of analgesia is more in patient given nalbuphine (118 vs 31) as maintenance analgesic agent in post-operative period after PCNL. Conclusion: This study showed that tramadol has superiority over nalbuphine for analgesia after PCNL.","PeriodicalId":319424,"journal":{"name":"Annals of Punjab Medical College","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Punjab Medical College","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29054/APMC/2021.1062","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Kidney stones has got high prevalence worldwide especially in our part of world and per-cutaneous nephrolithotomy (PCNL) is gold standard operative modality for renal stone management. Pain control after PCNL is the most important task for treating surgeon as effective pain control causes smooth patient recovery in post-operative period. For analgesia, many drugs can be used, out of which tramadol and nalbuphine always been in comparison for effective analgesic activity. Objective: To compare efficacy of tramadol and nalbuphine as potent analgesic in patients after PCNL. Study Design: A prospective randomized study. Settings: Department of Urology and Kidney Transplantation, Allied Hospital/Faisalabad Medical University, Faisalabad and Department of Urology, DHQ Hospital/Faisalabad Medical University, Faisalabad Pakistan. Duration: From September 2016 to September 2020 (4 Years). Methodology: 286 patients undergoing PCNL for either gender and sides enrolled in study according to inclusion and exclusion criteria. Patients divided into Group A (Administered with tramadol) and Group B (administered with nalbuphine) and patients evaluated for pain up to 48 hours after surgery using 11-point numerical pain rating scale rating from0-10 where 0 is no pain, 1-3 mild pain, 4-6 moderate pain, 7-9 severe pain and 10 as worst pain and use of rescue analgesia observed in either groups. Data obtained and statistical evaluation done. Results: 286 patients enrolled from age 15-75 years with mean age of 40.2 years. Among 286 patients, 161 were male and 125 were female patients. Both groups A and B having 143 patients each. Analysis showed that tramadol has superiority over nalbuphine and need of analgesia is more in patient given nalbuphine (118 vs 31) as maintenance analgesic agent in post-operative period after PCNL. Conclusion: This study showed that tramadol has superiority over nalbuphine for analgesia after PCNL.
背景:肾结石在世界范围内的发病率很高,尤其是在我国,经皮肾镜取石术(PCNL)是治疗肾结石的金标准手术方式。PCNL术后的疼痛控制是治疗外科医生最重要的任务,因为有效的疼痛控制可以使患者在术后顺利康复。在镇痛方面,有许多药物可供使用,其中曲马多和纳布啡的有效镇痛活性一直是比较的。目的:比较曲马多与纳布啡作为强效镇痛药在PCNL患者中的疗效。研究设计:前瞻性随机研究。环境:费萨拉巴德联合医院/费萨拉巴德医科大学泌尿科和肾移植科;巴基斯坦费萨拉巴德DHQ医院/费萨拉巴德医科大学泌尿科。学习时间:2016年9月至2020年9月(4年)。方法:根据纳入和排除标准纳入286例接受PCNL的患者。患者分为A组(曲马多给药)和B组(纳布啡给药),患者术后48小时的疼痛评分采用11点数值疼痛评定量表,0-10分,0为无疼痛,1-3轻度疼痛,4-6中度疼痛,7-9重度疼痛,10为最严重疼痛,两组均观察到使用抢救镇痛。获得数据并进行统计评估。结果:286例患者入组,年龄15-75岁,平均年龄40.2岁。286例患者中,男性161例,女性125例。A组和B组各143例。分析显示曲马多优于纳布啡,在PCNL术后给予纳布啡维持镇痛药的患者中,需要镇痛的患者较多(118 vs 31)。结论:曲马多在PCNL术后的镇痛效果优于纳布啡。